SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001553350-21-000890
Filing Date
2021-10-07
Accepted
2021-10-07 16:15:27
Documents
19
Period of Report
2021-10-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT htbx_8k.htm   iXBRL 8-K 26758
2 LEASE htbx_ex10z1.htm EX-10.1 311110
3 GRAPHIC image_001.jpg GRAPHIC 38112
4 GRAPHIC image_002.jpg GRAPHIC 86256
5 GRAPHIC image_003.jpg GRAPHIC 84164
6 GRAPHIC image_004.jpg GRAPHIC 81265
7 GRAPHIC image_005.jpg GRAPHIC 89309
8 GRAPHIC image_006.jpg GRAPHIC 47399
  Complete submission text file 0001553350-21-000890.txt   1177903

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE htbx-20211005.xsd EX-101.SCH 3040
10 XBRL LABEL FILE htbx-20211005_lab.xml EX-101.LAB 34240
11 XBRL PRESENTATION FILE htbx-20211005_pre.xml EX-101.PRE 22369
12 EXTRACTED XBRL INSTANCE DOCUMENT htbx_8k_htm.xml XML 3603
Mailing Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560
Business Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560 919-240-7133
HEAT BIOLOGICS, INC. (Filer) CIK: 0001476963 (see all company filings)

IRS No.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35994 | Film No.: 211312546
SIC: 2834 Pharmaceutical Preparations